A Bioavailability Study of Four Experimental BMS-708163 Formulations Relative to Solubilized Capsule Formulation in Healthy Young Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 18 Jan 2010
At a glance
- Drugs Avagacestat (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- 21 Aug 2009 Actual end date (1 Jul 2009) added as reported by ClinicalTrials.gov.
- 21 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Aug 2009 Planned end date changed from 1 Jul 2009 to 1 Aug 2009 as reported by ClinicalTrials.gov.